
### [DOID:4961](http://purl.obolibrary.org/obo/DOID_4961)
**Label:** bone marrow disease

**Subclasses:** [DOID:9538](http://purl.obolibrary.org/obo/DOID_9538) (multiple myeloma), [DOID:4971](http://purl.obolibrary.org/obo/DOID_4971) (myelofibrosis), [DOID:10780](http://purl.obolibrary.org/obo/DOID_10780) (primary polycythemia), 

**Corr. equiv. classes:** [OMIM:254450](http://purl.obolibrary.org/obo/OMIM_254450), [OMIM:254500](http://purl.obolibrary.org/obo/OMIM_254500), [OMIM:PS133100](http://purl.obolibrary.org/obo/OMIM_PS133100), 

**Class expressions from DL-Learner:**

- [HP:0011974](http://purl.obolibrary.org/obo/HP_0011974) (Myelofibrosis) 66.67%
- [HP:0011034](http://purl.obolibrary.org/obo/HP_0011034) (Amyloidosis) 66.67%
- [HP:0006775](http://purl.obolibrary.org/obo/HP_0006775) (Multiple myeloma) 66.67%
- [HP:0005547](http://purl.obolibrary.org/obo/HP_0005547) (Myeloproliferative disorder) 66.67%
- [HP:0011793](http://purl.obolibrary.org/obo/HP_0011793) (Neoplasm by anatomical site) and [HP:0012145](http://purl.obolibrary.org/obo/HP_0012145) (Abnormality of multiple cell lineages in the bone marrow) 66.67%
- [HP:0011793](http://purl.obolibrary.org/obo/HP_0011793) (Neoplasm by anatomical site) and [HP:0011974](http://purl.obolibrary.org/obo/HP_0011974) (Myelofibrosis) 66.67%
- [HP:0011034](http://purl.obolibrary.org/obo/HP_0011034) (Amyloidosis) and [HP:0031047](http://purl.obolibrary.org/obo/HP_0031047) (Paraproteinemia) 66.67%
- [HP:0010987](http://purl.obolibrary.org/obo/HP_0010987) (Abnormality of cellular immune system) and [HP:0011974](http://purl.obolibrary.org/obo/HP_0011974) (Myelofibrosis) 66.67%
- [HP:0006775](http://purl.obolibrary.org/obo/HP_0006775) (Multiple myeloma) and [HP:0031047](http://purl.obolibrary.org/obo/HP_0031047) (Paraproteinemia) 66.67%
- [HP:0005547](http://purl.obolibrary.org/obo/HP_0005547) (Myeloproliferative disorder) and [HP:0012145](http://purl.obolibrary.org/obo/HP_0012145) (Abnormality of multiple cell lineages in the bone marrow) 66.67%
- [HP:0005547](http://purl.obolibrary.org/obo/HP_0005547) (Myeloproliferative disorder) and [HP:0011974](http://purl.obolibrary.org/obo/HP_0011974) (Myelofibrosis) 66.67%
- [HP:0004377](http://purl.obolibrary.org/obo/HP_0004377) (Hematological neoplasm) and [HP:0012145](http://purl.obolibrary.org/obo/HP_0012145) (Abnormality of multiple cell lineages in the bone marrow) 66.67%
- [HP:0004377](http://purl.obolibrary.org/obo/HP_0004377) (Hematological neoplasm) and [HP:0011974](http://purl.obolibrary.org/obo/HP_0011974) (Myelofibrosis) 66.67%
- [HP:0002715](http://purl.obolibrary.org/obo/HP_0002715) (Abnormality of the immune system) and [HP:0011974](http://purl.obolibrary.org/obo/HP_0011974) (Myelofibrosis) 66.67%
- [HP:0002664](http://purl.obolibrary.org/obo/HP_0002664) (Neoplasm) and [HP:0012145](http://purl.obolibrary.org/obo/HP_0012145) (Abnormality of multiple cell lineages in the bone marrow) 66.67%


